New markers to predict the response to omalizumab in chronic spontaneous urticaria
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15589
Abstract: Omalizumab has high treatment efficacy in patients with chronic spontaneous urticaria (CSU) who do not respond to high doses of antihistamines. Systemic immune‐inflammation index (SII) and systemic inflammation response index (SIRI) were described as novel… read more here.
Keywords: sii siri; treatment; response; response omalizumab ... See more keywords
The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14235934
Abstract: Simple Summary Clinical management of Malignant Salivary Gland Tumors is still a challenge for clinicians. Direct and indirect costs for the diagnosis and treatment of these tumors are significant. For this reason, the need to… read more here.
Keywords: sii siri; combination; gland; salivary gland ... See more keywords